|
1
|
O'Reilly DA and Poston GJ: Colorectal
liver metastases: Current and future perspectives. Future Oncol.
2:525–531. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fong Y, Fortner J, Sun RL, Brennan MF and
Blumgart LH: Clinical score for predicting recurrence after hepatic
resection for metastatic colorectal cancer: Analysis of 1001
consecutive cases. Ann Surg. 230:309–321. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Malik HZ, Prasad KR, Halazun KJ, Aldoori
A, Al-Mukhtar A, Gomez D, Lodge JP and Toogood GJ: Preoperative
prognostic score for predicting survival after hepatic resection
for colorectal liver metastases. Ann Surg. 246:806–814. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simmonds PC, Primrose JN, Colquitt JL,
Garden OJ, Poston GJ and Rees M: Surgical resection of hepatic
metastases from colorectal cancer: A systematic review of published
studies. Br J Cancer. 94:982–999. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Loupakis F, Cremolini C, Masi G, Lonardi
S, Zagonel V, Salvatore L, Cortesi E, Tomasello G, Ronzoni M, Spadi
R, et al: Initial therapy with FOLFOXIRI and bevacizumab for
metastatic colorectal cancer. N Engl J Med. 371:1609–1618. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Simkens LH, van Tinteren H, May A, ten
Tije AJ, Creemers GJ, Loosveld OJ, de Jongh FE, Erdkamp FL, Erjavec
Z, van der Torren AM, et al: Maintenance treatment with
capecitabine and bevacizumab in metastatic colorectal cancer
(CAIRO3): A phase 3 randomised controlled trial of the Dutch
Colorectal Cancer Group. Lancet. 385:1843–1852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Proctor MJ, Morrison DS, Talwar D, Balmer
SM, O'Reilly DS, Foulis AK, Horgan PG and McMillan DC: An
inflammation-based prognostic score (mGPS) predicts cancer survival
independent of tumor site: A Glasow inflammation outcome study. Br
J Cancer. 104:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McMillan DC: An inflammation-based
prognostic score and its role in the nutrition-based management of
patients with cancer. Proc Nutr Soc. 67:257–262. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Halazun KJ, Aldoori A, Malik HZ,
Al-Mukhtar A, Prasad KR, Toogood GJ and Lodge JP: Elevated
preoperative neutrophil to lymphocyte ratio predicts survival
following hepatic resection for colorectal liver metastases. Eur J
Surg Oncol. 34:55–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giakoustidis A, Neofytou K, Khan AZ and
Mudan S: Neutrophil to lymphocyte ratio predicts pattern of
recurrence in patients undergoing liver resection for colorectal
liver metastasis and thus the overall survival. J Surg Oncol.
111:445–450. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gomez D, Morris-Stiff G, Wyatt J, Toogood
GJ, Lodge JP and Prasad KR: Surgical technique and systemic
inflammation influences long-term disease-free survival following
hepatic resection for colorectal metastasis. J Surg Oncol.
98:371–376. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mano Y, Shirabe K, Yamashita Y, Harimoto
N, Tsujita E, Takeishi K, Aishima S, Ikegami T, Yoshizumi T,
Yamanaka T and Maehara Y: Preoperative neutrophil-to-lymphocyte
ratio is a predictor of survival after hepatectomy for
hepatocellular carcinoma: A retrospective analysis. Ann Surg.
258:301–305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujiwara Y, Shiba H, Furukawa K, Iida T,
Haruki K, Gocho T, Wakiyama S, Hirohara S, Ishida Y, Misawa T, et
al: Glasgow prognostic score is related to blood transfusion
requirements and post-operative complications in hepatic resection
for hepatocellular carcinoma. Anticancer Res. 30:5129–5136.
2010.PubMed/NCBI
|
|
14
|
Haruki K, Shiba H, Fujiwara Y, Furukawa K,
Wakiyama S, Ogawa M, Ishida Y, Misawa T and Yanaga K: Negative
impact of surgical site infection on long-term outcomes after
hepatic resection for colorectal liver metastases. Anticancer Res.
33:1697–1703. 2013.PubMed/NCBI
|
|
15
|
Fujiwara Y, Shiba H, Furukawa K, Iida T,
Sakamoto T, Gocho T, Wakiyama S, Hirohara S, Ishida Y, Misawa T, et
al: Perioperative change in white blood cell count predicts outcome
of hepatic resection for hepatocellular carcinoma. J Hepatobiliary
Pancreat Sci. 17:892–897. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shiba H, Furukawa K, Fujiwara Y, Futagawa
Y, Haruki K, Wakiyama S, Ishida Y, Misawa T and Yanaga K:
Postoperative peak serum C-reactive protein predicts outcome of
hepatic resection for hepatocellular carcinoma. Anticancer Res.
33:705–709. 2013.PubMed/NCBI
|
|
17
|
Haruki K, Shiba H, Fujiwara Y, Furukawa K,
Wakiyama S, Ogawa M, Ishida Y, Misawa T and Yanaga K: Perioperative
change in peripheral blood monocyte count may predict prognosis in
patients with colorectal liver metastasis after hepatic resection.
J Surg Oncol. 106:31–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miyagawa S, Makuuchi M, Kawasaki S and
Kakazu T: Criteria for safe hepatic resection. Am J Surg.
169:589–594. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Strasberg SM: Nomenclature of hepatic
anatomy and resections: A review of the Brisbane 2000 system. J
Hepatobiliary Pancreat Surg. 12:351–355. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jaiswal M, LaRusso NF, Burgart LJ and
Gores GJ: Inflammatory cytokines induce DNA repair in
cholangiocarcinoma cells by a nitricoxide-dependent mechanism.
Cancer Res. 60:184–190. 2000.PubMed/NCBI
|
|
22
|
McMillan DC, Canna K and McArdle CS:
Systemic inflammatory response predicts survival following curative
resection of colorectal cancer. Br J Surg. 90:215–219. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kobayashi T, Teruya M, Kishiki T, Endo D,
Takenaka Y, Miki K, Kobayashi K and Morita K: Elevated C-reactive
protein and hypoalbuminemia measured before resection of colorectal
live rmetastases predict postoperative survival. Dig Surg.
27:285–290. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Neal CP, Mann CD, Garcea G, Briggs CD,
Dennison AR and Berry DP: Preoperative systemic inflammation and
infectious complications after resection of colorectal liver
metastases. Arch Surg. 146:471–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taichman NS, Young S, Cruchley AT, Taylor
P and Paleolog E: Human neutrophils secrete vascular endothelial
growth factor. J Leukoc Biol. 62:397–400. 1997.PubMed/NCBI
|
|
27
|
Maniwa Y, Okada M, Ishii N and Kiyooka K:
Vascular endothelial growth factor increased by pulmonary surgery
accelerates the growth of micrometastases in metastatic lung
cancer. Chest. 114:1668–1675. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Farid SG, Aldouri A, Morris-Stiff G, Khan
AZ, Toogood GJ, Lodge JP and Prasad KR: Correlation between
postoperative infective complications and long-term outcomes after
hepatic resection for colorectal liver metastasis. Ann Surg.
251:91–100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakano H, Oussoultzoglou E, Rosso E,
Casnedi S, Chenard-Neu MP, Dufour P, Bachellier P and Jaeck D:
Sinusoidal injury increases morbidity after major hepatectomy in
patients with colorectal liver metastases receiving preoperative
chemotherapy. Ann Surg. 247:118–124. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vauthey JN, Pawlik TM, Ribero D, Wu TT,
Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, et
al: Chemotherapy regimen predicts steatohepatitis and an increase
in 90-day mortality after surgery for hepatic colorectal
metastases. J Clin Oncol. 24:2065–2072. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Viganò L, Capussotti L, De Rosa G, De
Saussure WO, Mentha G and Rubbia-Brandt L: Liver resection for
colorectal metastases after chemotherapy: Impact of
chemotherapy-related liver injuries, pathological tumor response,
and micrometastases on long-term survival. Ann Surg. 258:731–742.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leal JN, Bressan AK, Vachharajani N, Gonen
M, Kingham TP, D'Angelica MI, Allen PJ, DeMatteo RP, Doyle MB,
Bathe OF, et al: Time-to-surgery and survival outcomes in
resectable colorectal liver metastases: A multi-institutional
evaluation. J Am Coll Surg. 222:766–779. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Balkwill F and Mantovani A: Cancer and
inflammation: Implications for pharmacology and therapeutics. Clin
Pharmacol Ther. 87:401–406. 2010. View Article : Google Scholar : PubMed/NCBI
|
